Quantitative analysis for Mesoblast Limited (MESO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (67.0) (grade B). 29 signals analyzed (25 differentiated alt-data).
MESO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $15.70 | $15.47 | $15.55 |
| 2026-05-11 | $14.78 | $14.50 | $14.51 |
| 2026-05-21 | $15.02 | $14.63 | $14.98 |
| 2026-06-03 | $14.55 | $14.27 | $14.52 |
| 2026-06-15 | $14.02 | $13.76 | $13.76 |
| 2026-06-26 | $13.35 | $13.05 | $13.19 |
| 2026-07-09 | $14.86 | $14.63 | $14.83 |
| 2026-07-21 | $16.43 | $16.10 | $16.42 |
| 2026-07-31 | $14.53 | $14.05 | $14.17 |
| 2026-08-12 | $17.07 | $16.72 | $16.78 |
| 2026-08-24 | $16.80 | $16.44 | $16.64 |
| 2026-09-03 | $17.29 | $16.94 | $17.14 |
How Mesoblast Limited stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PHVS | Pharvaris N.V. | $1.9B | 72.0 |
| LKFT | Galapagos N.V. Sponsored ADR | $1.8B | — |
| BHC | Bausch Health Companies Inc. | $2.1B | 33.0 |
| ESTA | Establishment Labs Holdings Inc. | $2.1B | — |
View all Health Care stocks by valuation and signals →
Mesoblast Limited (MESO) scores Buy (67.0), with no measured dimension below 45. Its highest are technicals at 82, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 82 |
| analyst consensus | 45 |
StoQuant analyzes 29 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Mesoblast Limited (MESO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/MESO"><img src="https://stoquant.com/badge/MESO.svg" alt="Mesoblast Limited (MESO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.